Almstead Neil Gregory's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Jan 12, 2026
- Accession no.
- 0001578850-26-000006
- Filed
- Jan 12, 2026
- Trade date
- Jan 8, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $71.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Almstead Neil GregoryCIK 0001578850 | Officer (CHIEF TECHNICAL OPS OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | Common Stock | SSaleDisposed | −881 | $76.45 | −$67,352.45 | 115,196 | Direct | |
| Jan 8, 2026 | Common Stock | SSaleDisposed | −59 | $76.45 | −$4,510.55 | 6,791 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.